Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Hongwei Li was the last independent director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Anuncio • Apr 28
LB Group Co., Ltd., Annual General Meeting, May 18, 2026 LB Group Co., Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Hebei China Anuncio • Mar 31
LB Group Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026 LB Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Anuncio • Dec 31
LB Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 LB Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Anuncio • Oct 29
LB Group Co., Ltd. Proposes Cash Dividend (Tax Included) for Third Quarter 2025 LB Group Co., Ltd. at the Extraordinary General Meeting of 2025 held on 12 November 2025, proposed cash dividend (tax included) for third quarter 2025 of CNY 1.00000000 per 10 shares. Anuncio • Sep 30
LB Group Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 LB Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Anuncio • Jul 02
LB Group Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025 LB Group Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 Anuncio • Jun 06
LB Group Co., Ltd. Announces First Quarter Distribution, Payable on June 11, 2025 LB Group Co., Ltd. announced that the 2025 1st quarter profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.00. Record date: 10 June 2025. Ex-date: 11 June 2025. Payment date: 11 June 2025. Anuncio • Apr 25
LB Group Co., Ltd. Proposes Cash Dividend for the First Quarter 2025 LB Group Co., Ltd. proposed first quarter 2025 cash dividend of CNY 5.00000000 per 10 shares (tax included). Anuncio • Apr 24
LB Group Co., Ltd., Annual General Meeting, May 14, 2025 LB Group Co., Ltd., Annual General Meeting, May 14, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China Anuncio • Mar 31
LB Group Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025 LB Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Anuncio • Dec 31
LB Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 LB Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025 Anuncio • Nov 15
LB Group Co., Ltd. Approves 3rd Quarter Profit Distribution Plan for 2024 LB Group Co., Ltd. held its 2nd Extraordinary General Meeting of 2024 on 13 November 2024, during were approved 2024 3rd quarter profit distribution plan as Cash dividend/10 shares (tax included): CNY 3.00000000. Anuncio • Oct 30
LB Group Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2024 LB Group Co., Ltd. announced profit distribution proposal for the third quarter of 2024. For the quarter, the company reported Cash dividend/10 shares (tax included) is CNY 3.00000000. Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.36 (vs CN¥0.37 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.36 (down from CN¥0.37 in 3Q 2023). Revenue: CN¥7.09b (up 1.1% from 3Q 2023). Net income: CN¥842.2m (down 4.3% from 3Q 2023). Profit margin: 12% (in line with 3Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Anuncio • Sep 30
LB Group Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 LB Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥19.38, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years. Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.29 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.31 (up from CN¥0.29 in 2Q 2023). Revenue: CN¥6.52b (up 3.8% from 2Q 2023). Net income: CN¥770.4m (up 13% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings. Anuncio • Jun 29
LB Group Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 LB Group Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Anuncio • Jun 18
LB Group Co., Ltd. (SZSE:002601) announces an Equity Buyback for CNY 200 million worth of its shares. LB Group Co., Ltd. (SZSE:002601) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The shares will be purchased at a price not exceeding CNY 32.10 per share. The purpose of the program is to further establish and improve the company's long-term incentive mechanism, attract and retain outstanding talents, safeguard the legitimate rights and interests of all shareholders of the company, and promote the stable and healthy development of the company. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be funded from company's own funds. The program will be valid for 12 months. Declared Dividend • May 27
Dividend of CN¥0.60 announced Dividend of CN¥0.60 is the same as last year. Ex-date: 30th May 2024 Payment date: 30th May 2024 Dividend yield will be 4.1%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (19% earnings payout ratio) but not covered by cash flows (177% cash payout ratio). The dividend has increased by an average of 51% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 53% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Anuncio • May 25
Lb Group Co., Ltd. Approves the Cash Dividend of A Shares for the First Quarter of 2024, Payable on 30 May 2024 LB Group Co., Ltd. approved the cash dividend of CNY 6.00000000 per 10 A shares (tax included) for the first quarter of 2024. Record date is 29 May 2024. Ex-date is 30 May 2024. Payment date is 30 May 2024. Anuncio • Apr 24
LB Group Co., Ltd., Annual General Meeting, May 14, 2024 LB Group Co., Ltd., Annual General Meeting, May 14, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China Reported Earnings • Apr 24
First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.24 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.41 (up from CN¥0.24 in 1Q 2023). Revenue: CN¥7.29b (up 4.6% from 1Q 2023). Net income: CN¥951.1m (up 64% from 1Q 2023). Profit margin: 13% (up from 8.3% in 1Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 18% per year. Anuncio • Mar 30
LB Group Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024 LB Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024 Anuncio • Dec 30
LB Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024 LB Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024 Anuncio • Nov 02
LB Group Co., Ltd. Implements 3rd Quarter Profit Distribution Plan for 2023, payable on 08 November 2023 LB Group Co., Ltd. announced 2023 3rd quarter profit distribution plan to be implemented (A shares) Cash dividend/10 shares (tax included): CNY 3.00000000. Record date: 07 November 2023, Ex-date: 08 November 2023, Payment date: 08 November 2023. Anuncio • Nov 01
LB Group Co., Ltd. Approves Cash Dividend for the Third Quarter of 2023 LB Group Co., Ltd. in its 7th Extraordinary General Meeting of 2023 on 30 October 2023 approved the cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023. Anuncio • Oct 17
LB Group Co., Ltd. Proposes Quarterly Cash Dividend for the Third Quarter of 2023 LB Group Co., Ltd. proposed quarterly cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023. Reported Earnings • Oct 14
Third quarter 2023 earnings released: EPS: CN¥0.37 (vs CN¥0.40 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.37 (down from CN¥0.40 in 3Q 2022). Revenue: CN¥7.04b (up 25% from 3Q 2022). Net income: CN¥880.0m (down 3.0% from 3Q 2022). Profit margin: 13% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 11% per year, which means it is performing significantly worse than earnings. Reported Earnings • Aug 26
Second quarter 2023 earnings released: EPS: CN¥0.29 (vs CN¥0.57 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.57 in 2Q 2022). Revenue: CN¥6.29b (flat on 2Q 2022). Net income: CN¥682.6m (down 43% from 2Q 2022). Profit margin: 11% (down from 19% in 2Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Anuncio • May 24
LB Group Co., Ltd. Approves Cash Dividend on A Shares for the First Quarter of 2023, Payable on May 29, 2023 LB Group Co., Ltd. approved Cash dividend/10 shares (tax included) of CNY 6.00000000 on A shares for the first quarter of 2023, payable on May 29, 2023. Record date: May 26, 2023; and Ex-date: May 29, 2023. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.45 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.45 in 1Q 2022). Revenue: CN¥6.98b (up 15% from 1Q 2022). Net income: CN¥579.4m (down 46% from 1Q 2022). Profit margin: 8.3% (down from 18% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.76 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.76 in 3Q 2021). Revenue: CN¥5.66b (up 4.3% from 3Q 2021). Net income: CN¥907.0m (down 35% from 3Q 2021). Profit margin: 16% (down from 26% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Sep 17
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 20%. The fair value is estimated to be CN¥20.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 42% in 2 years. Earnings is forecast to grow by 32% in the next 2 years. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.60 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.57 (down from CN¥0.60 in 2Q 2021). Revenue: CN¥6.36b (up 22% from 2Q 2021). Net income: CN¥1.20b (down 12% from 2Q 2021). Profit margin: 19% (down from 26% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 23%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Board Change • May 27
High number of new directors There are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 14
Full year 2021 earnings released Full year 2021 results: Net income: CN¥4.68b (up 104% from FY 2020). Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.76 (vs CN¥0.32 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥5.47b (up 53% from 3Q 2020). Net income: CN¥1.40b (up 113% from 3Q 2020). Profit margin: 26% (up from 18% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorated over the past week After last week's 19% share price decline to CN¥28.24, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 148% over the past three years. Reported Earnings • Aug 24
Second quarter 2021 earnings released: EPS CN¥0.60 (vs CN¥0.20 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.22b (up 98% from 2Q 2020). Net income: CN¥1.37b (up 250% from 2Q 2020). Profit margin: 26% (up from 15% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 14
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥36.42, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 228% over the past three years. Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥30.61, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 199% over the past three years. Reported Earnings • Apr 17
Full year 2020 earnings released: EPS CN¥1.13 (vs CN¥1.29 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥14.2b (up 25% from FY 2019). Net income: CN¥2.29b (down 12% from FY 2019). Profit margin: 16% (down from 23% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment deteriorated over the past week After last week's 21% share price decline to CN¥27.26, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 79% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.54 per share. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment deteriorated over the past week After last week's 23% share price decline to CN¥32.00, the stock is trading at a trailing P/E ratio of 26.4x, down from the previous P/E ratio of 34.4x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 107%. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥48.48, the stock is trading at a trailing P/E ratio of 40x, up from the previous P/E ratio of 33.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 236%. Is New 90 Day High Low • Feb 11
New 90-day high: CN¥48.48 The company is up 61% from its price of CN¥30.06 on 13 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.71 per share. Is New 90 Day High Low • Jan 21
New 90-day high: CN¥41.43 The company is up 67% from its price of CN¥24.76 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.66 per share. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥35.72, the stock is trading at a trailing P/E ratio of 29.5x, up from the previous P/E ratio of 25.4x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 149%. Is New 90 Day High Low • Jan 05
New 90-day high: CN¥35.12 The company is up 51% from its price of CN¥23.29 on 30 September 2020. The Chinese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.79 per share. Valuation Update With 7 Day Price Move • Nov 13
Market bids up stock over the past week After last week's 16% share price gain to CN¥30.06, the stock is trading at a trailing P/E ratio of 24.8x, up from the previous P/E ratio of 21.4x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 141%. Valuation Update With 7 Day Price Move • Nov 11
Market bids up stock over the past week After last week's 17% share price gain to CN¥29.30, the stock is trading at a trailing P/E ratio of 24.2x, up from the previous P/E ratio of 20.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 126%. Is New 90 Day High Low • Nov 11
New 90-day high: CN¥29.30 The company is up 26% from its price of CN¥23.25 on 13 August 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥11.72 per share. Reported Earnings • Nov 03
Third quarter 2020 earnings released: EPS CN¥0.32 The company reported a soft third quarter result with weaker earnings and profit margins, although revenues were improved. Third quarter 2020 results: Revenue: CN¥3.61b (up 24% from 3Q 2019). Net income: CN¥656.8m (down 18% from 3Q 2019). Profit margin: 18% (down from 27% in 3Q 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Oct 13
Market bids up stock over the past week After last week's 21% share price gain to CN¥28.25, the stock is trading at a trailing P/E ratio of 21.9x, up from the previous P/E ratio of 18.1x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past three years are 92%. Is New 90 Day High Low • Oct 12
New 90-day high: CN¥26.61 The company is up 12% from its price of CN¥23.83 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥10.92 per share.